Gastroenterology
Volume 122, Issue 1 , Pages 44-54 , January 2002

Mucosal flora in inflammatory bowel disease

Received 19 January 2001 ,Accepted 6 September 2001.

References 

  1. Campieri M, Gionchetti P. Bacteria as the cause of ulcerative colitis. Gut. 2001;48:132–135
  2. Rath HC, Ikeda JS, Linde HJ, Schölmerich J, Wilson KH, Sartor RB. Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology. 1999;116:310–319
  3. Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol. 1997;148:567–576
  4. Edmiston CE, Avant GR, Wilson FW. Anaerobic bacterial population on normal and diseased human biopsy tissue obtained at colonoscopy. Appl Environ Microbiol. 1992;43:1173–1181
  5. Liu Y, Kruiningen JV, West AB, Cartun RW, Cortot A, Colombel J-F. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology. 1995;108:1396–1404
  6. Sutton CL, Kim J, Yamane A, Dalwadi H, Wie B, Landers C, et al. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology. 2000;119:23–31
  7. Swidsinski A, Khilkin M, Schreiber S, Lehman C, Ortner M, Liebers U, et al. Evaluation of the epithelial barrier in inflammatory bowel disease using 16S rRNA sequences of adherent bacteria (abstr). Gastroenterology. 1996;110:A1023
  8. Malchow H, Ewe K, Brandes JW, Goebell HM, Ehms H, Sommer H, et al. European cooperative Crohn's disease study (ECCDS): results of drug treatment. Gastroenterology. 1984;86:249–266
  9. Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut. 1986;27:1210–1212
  10. Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology. 1998;115:281–286
  11. Snaidr J, Amann R, Huber I, Ludwig W, Schleifer KH. Phylogenetic analysis and in-situ identification of bacteria in activated sludge. Appl Environ Microbiol. 1997;63:2884–2896
  12. Amann R, Binder IBJ, Olson RJ, Chisholm SW, Devereux R, Stahl DA. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol. 1990;56:1919–1925
  13. Manz W, Amann R, Ludwig W, Wagner M, Schleifer KH. Phylogenetic oligodeoxynucleotide probes for the major subclasses of proteobacteria: problems and solutions. Syst Appl Microbiol. 1992;15:593–600
  14. Manz W, Amann R, Ludwig W, Vancanneyt M, Schleifer KH. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylumcytophaga- flavobacter- bacteroides in the natural environment. Microbiology. 1996;142:1097–1106
  15. Hudson MJ, Hill MJ, Elliot PJ, Berghouse LM, Burnham WR, Lennard-Jones JE. The microbial flora of the rectal mucosa and feces of patients with Crohn's disease before and during antimicrobial chemotherapy. J Med Microbiol. 1984;18:335–345
  16. Hartley MG, Hudson MJ, Swarbrick ET, Hill MJ, Gent AE, Hellier MD, et al. The rectal mucosa-associated microflora in patients with ulcerative colitis. J Med Microbiol. 1992;36:96–103
  17. Poxton IR, Brown R, Sawyerr A, Ferguson A. Mucosa-associated bacterial flora of the human colon. J Med Microbiol. 1997;46:85–91
  18. Tanaka K, Wilks M, Coates PJ, Farthing MJG, Walker-Smith JA, Tabaqchali S. Mycobacterium paratuberculosis and Crohn's disease. Gut. 1991;32:43–45
  19. Rath HC, Wilson KH, Sartor RB. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun. 1999;67:2969–2974
  20. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm ThE, Balish E, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/Human β2 microglobulin transgenic rats. J Clin Invest. 1996;98:945–953
  21. Madsen KL, Doyle JS, Tavernini MM, Jewell LD, Rennie RP, Fedorak RN. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology. 2000;118:1094–1105
  22. Burke DA, Axon ATR. Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. BMJ. 1988;297:102–104
  23. Giaffer MH, Holdsworth CD, Duerden BI. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut. 1992;33:646–650
  24. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di-Martino P, Desreumaux P, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998;115:1405–1413
  25. Schultsz C, Van Den Berg FM, Ten Kate FW, Tytgat GNJ, Dankert J. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology. 1999;117:1089–1097
  26. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599–603
  27. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603–606
  28. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, et al. An insertion mutation in the NOD2 gene predisposes to Crohn's disease in the German and British populations. Lancet. 2001;357:1925–1928
  29. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF{kappa}B. J Biol Chem. 2001;276:4812–4818
  30. Inohara N, Ogura Y, Chen FF, Muto A, Nunez G. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem. 2000;4:2551–2554
  31. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor kappa B in inflammatory bowel disease. Gut. 1998;42:477–485

☆ Address requests for reprints to: Alexander Swidsinski, M.D., Innere Klinik, Gastroenterologie, Charité, 10098 Berlin, Germany. e-mail: alexander.swidsinski@charite.de; fax: (011) 49 30 450 514 923.

PII: S0016-5085(02)29245-8

Gastroenterology
Volume 122, Issue 1 , Pages 44-54 , January 2002

Article Tools

* Image Usage & Resolution